The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Published:2021-04 Issue:5 Volume:160 Page:1608-1619.e13
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Younossi Zobair M.,Anstee Quentin M.,Wai-Sun Wong Vincent,Trauner Michael,Lawitz Eric J.,Harrison Stephen A.,Camargo Marianne,Kersey Kathryn,Subramanian G. Mani,Myers Robert P.,Stepanova Maria

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology,2019

2. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States;Le;PLoS One,2017

3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

4. Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States;Younossi;Hepatology,2019

5. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating liver endpoints in clinical trials of cardiovascular and kidney disease;Nature Medicine;2024-09-03

2. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-09

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. Creating a framework for an integrated novel ultrasound clinic for metabolic dysfunction-associated steatotic liver disease;British Journal of Healthcare Management;2024-06-02

5. Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease;Alimentary Pharmacology & Therapeutics;2024-05-30